Callum Sloss

Callum Sloss has a diverse work experience in the field of translational sciences and medicine. Callum worked at ImmunoGen, Inc. from 2015 onwards, where they held positions as Senior Director, Translational Sciences; Director, Translational Medicine; and Associate Director, Translational Medicine. Prior to that, they were with Merrimack Pharmaceuticals as a Principal Scientist and Senior Scientist. Callum also worked as a Postdoctoral Fellow at MGH/Harvard and as a Teaching & Research Fellow at the University of Strathclyde.

Callum Sloss completed their Bachelor's Degree in Molecular Biology and Biochemistry at the University of Strathclyde from 1994 to 1998. Following this, they pursued a PhD in the same field at the same university from 1998 to 2003.